Jump to main content
Jump to site search

Issue 5, 2011
Previous Article Next Article

Molecular obesity, potency and other addictions in drug discovery

Author affiliations

Abstract

Despite the increase in global biology and chemistry knowledge the discovery of effective and safe new drugs seems to become harder rather than easier. Some of this challenge is due to increasing demands for safety and novelty, but some of the risk involved in this should be controllable if we had more effectively learnt from our failures. This perspective reflects on some of the learnings of recent years in relation to the causes of attrition. The term Molecular Obesity is introduced to describe our tendency to build potency into molecules by the inappropriate use of lipophilicity which leads to the premature demise of drug candidates.

Graphical abstract: Molecular obesity, potency and other addictions in drug discovery

Back to tab navigation

Publication details

The article was received on 18 Jan 2011, accepted on 14 Feb 2011 and first published on 07 Mar 2011


Article type: Review Article
DOI: 10.1039/C1MD00017A
Citation: Med. Chem. Commun., 2011,2, 349-355
  •   Request permissions

    Molecular obesity, potency and other addictions in drug discovery

    M. M. Hann, Med. Chem. Commun., 2011, 2, 349
    DOI: 10.1039/C1MD00017A

Search articles by author

Spotlight

Advertisements